31.05.2023 14:45:27

EQS-PVR: Dermapharm Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Voting Rights Announcement: Dermapharm Holding SE
Dermapharm Holding SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

31.05.2023 / 14:45 CET/CEST
Dissemination of a Voting Rights Announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Notification of Major Holdings

1. Details of issuer
Name: Dermapharm Holding SE
Street: Lil-Dagover-Ring 7
Postal code: 82031
City: Grünwald
Germany
Legal Entity Identifier (LEI): 5299009F0KNZINQQQK37

2. Reason for notification
X Acquisition/disposal of shares with voting rights
  Acquisition/disposal of instruments
  Change of breakdown of voting rights
  Other reason:

3. Details of person subject to the notification obligation
Legal entity: Mawer Investment Management Ltd
City of registered office, country: Calgary, Canada

4. Names of shareholder(s)
holding directly 3% or more voting rights, if different from 3.
 

5. Date on which threshold was crossed or reached:
25 May 2023

6. Total positions
  % of voting rights attached to shares
(total of 7.a.)		 % of voting rights through instruments
(total of 7.b.1 + 7.b.2)		 Total of both in %
(7.a. + 7.b.)		 Total number of voting rights pursuant to Sec. 41 WpHG
New 3.004093610698 % 0.00 % 3.004093610698 % 53840000
Previous notification n/a % n/a % n/a % /

7. Details on total positions
a. Voting rights attached to shares (Sec. 33, 34 WpHG)
ISIN Absolute In %
  Direct
(Sec. 33 WpHG)		 Indirect
(Sec. 34 WpHG)		 Direct
(Sec. 33 WpHG)		 Indirect
(Sec. 34 WpHG)
DE000A2GS5D8 0 1617404 0.00 % 3.00 %
Total 1617404 3.004093610698 %

b.1. Instruments according to Sec. 38 (1) no. 1 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Voting rights absolute Voting rights in %
0 0.00 %
    Total 0 0.00 %

b.2. Instruments according to Sec. 38 (1) no. 2 WpHG
Type of instrument Expiration or maturity date Exercise or conversion period Cash or physical settlement Voting rights absolute Voting rights in %
0 0.00 %
      Total 0 0.00 %

8. Information in relation to the person subject to the notification obligation
X Person subject to the notification obligation is not controlled nor does it control any other undertaking(s) that directly or indirectly hold(s) an interest in the (underlying) issuer (1.).
  Full chain of controlled undertakings starting with the ultimate controlling natural person or legal entity:

Name % of voting rights (if at least 3% or more) % of voting rights through instruments (if at least 5% or more) Total of both (if at least 5% or more)

9. In case of proxy voting according to Sec. 34 para. 3 WpHG
(only in case of attribution of voting rights in accordance with Sec. 34 para. 1 sent. 1 No. 6 WpHG)

Date of general meeting:
Holding total positions after general meeting (6.) after annual general meeting:
Proportion of voting rights Proportion of instruments Total of both
% % %

10. Other explanatory remarks:
 

Date
29 May 2023


31.05.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com
Language: English
Company: Dermapharm Holding SE
Lil-Dagover-Ring 7
82031 Grünwald
Germany
Internet: ir.dermapharm.de

 
End of News EQS News Service

1646179  31.05.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1646179&application_name=news&site_id=smarthouse
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!

Nachrichten zu Dermapharm Holding SEmehr Nachrichten

Analysen zu Dermapharm Holding SEmehr Analysen

05.12.24 Dermapharm Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
28.11.24 Dermapharm Buy Jefferies & Company Inc.
15.11.24 Dermapharm Buy Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
14.11.24 Dermapharm Buy Jefferies & Company Inc.
06.09.24 Dermapharm Buy Jefferies & Company Inc.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Newssuche

GO

Aktien in diesem Artikel

Dermapharm Holding SE 39,20 2,35% Dermapharm Holding SE

Letzte Top-Ranking Nachrichten

21:47 Commerzbank-Depot im vierten Quartal 2024: Diese US-Aktien sind im Portfolio - NVIDIA- und Amazon reduziert
02.03.25 KW 9: Das sind die Tops und Flops der DAX-Aktien
02.03.25 KW 9: So performten die ATX-Aktien in der vergangenen Woche
02.03.25 Bitcoin, Ether & Co. im Februar 2025: Monatsbilanz der Kryptowährungen
02.03.25 Februar 2025: Die Tops und Flops unter den Rohstoffen im abgelaufenen Monat

Börse aktuell - Live Ticker

ATX letztlich höher -- DAX schließt nach Rekord erstmals über 23.000-Punkte-Marke -- Wall Street beendet Handel tiefrot -- Asiens Börsen letztlich uneins
Der heimische Aktienmarkt zeigte sich in Grün, während der deutsche Aktienmarkt zum Wochenauftakt höher notierte. Die Wall Street präsentierte sich zum Wochenanfang mit negativen Vorzeichen. Am Montag fanden die wichtigsten asiatischen Märkten keine gemeinsame Richtung.

Nachrichten

Aktien ATX  DAX  EuroStoxx 50  Dow Jones  NASDAQ 100  Nikkei 225  S&P 500 

Kontakt  - Impressum - Werbung

Sitemap  - Datenschutz  - Disclaimer  - AGB  - Privatsphäre-Einstellungen